Although both Ctrl and dCKO mice progressed to prostate cancer at 40 weeks of age (Supplemental Fig. S1g), Kaplan–Meier analysis demonstrated that dCKO mice exhibited shorter overall survival (OS) than the Ctrl group (P = 0.0094, Fig. 1h). The gene discussed is CTRL; the disease is prostate carcinoma.